Pluri (PLUR) Operating Margin (QoQ) (2011 - 2025)
Powered by 
Analysis
Pluri (PLUR) Operating Margin (QoQ) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Pluri | 11.95 Mn | -536,034.04 | 86,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -127,636.00 |
| Sep 30, 2025 | -34,593.00 |
| Jun 30, 2025 | -39,893.00 |
| Mar 31, 2025 | 141,482.00 |
| Dec 31, 2024 | -108,498.00 |
| Sep 30, 2024 | 469,094.00 |
| Jun 30, 2024 | 150,895.00 |
| Mar 31, 2024 | -282,960.00 |
| Dec 31, 2023 | 499,265.00 |
| Sep 30, 2023 | -406,191.00 |
| Jun 30, 2023 | 226,542.00 |
| Mar 31, 2023 | 32.58 Mn |
| Dec 31, 2022 | -32.60 Mn |
| Dec 31, 2018 | 20.76 Mn |
| Dec 31, 2015 | 566,005.00 |
| Dec 31, 2014 | -71,368.00 |
| Sep 30, 2014 | 122,254.00 |
| Jun 30, 2014 | 263,430.00 |
| Mar 31, 2014 | -241,789.00 |
| Dec 31, 2013 | -224,211.00 |